These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11562179)

  • 21. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
    Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
    Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C
    Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
    Aaltonen K; Blomqvist C; Amini RM; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H
    Clin Cancer Res; 2008 Apr; 14(7):1976-83. PubMed ID: 18381935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
    Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
    Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2.
    Liede A; Narod SA
    Hum Mutat; 2002 Dec; 20(6):413-24. PubMed ID: 12442265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
    Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
    Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Search for frequently encountered mutations in genes predisposing to breast cancer].
    Mandel'shtam MIu; Golubkov VI; Lamber EP; Shapiro IM; Brezhneva TV; Semiglazov VF; Lipovetskiĭ BM; Hanson KP; Gaĭtskhoki VS
    Genetika; 2001 Dec; 37(12):1681-6. PubMed ID: 11785296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer: epidemiology and risk factors.
    Stuckey A
    Clin Obstet Gynecol; 2011 Mar; 54(1):96-102. PubMed ID: 21278508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk prediction models for familial breast cancer.
    Antoniou AC; Easton DF
    Future Oncol; 2006 Apr; 2(2):257-74. PubMed ID: 16563094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of breast cancer.
    Goldman R; Shields PG
    In Vivo; 1998; 12(1):43-8. PubMed ID: 9575425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial breast cancer.
    Dunn J; Farndon JR
    J R Coll Surg Edinb; 1991 Jun; 36(3):147-51. PubMed ID: 1920225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetic epidemiology of cancer.
    Claus EB
    Cancer Surv; 1995; 25():13-26. PubMed ID: 8718511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers of risk for human malignancies.
    Garber JE
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):471-83. PubMed ID: 8707768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular biology of breast carcinoma. Current diagnostic, therapeutic and prognostic aspects].
    Schwarz LE; Schlag PM
    Zentralbl Chir; 1998; 123 Suppl 5():6-12. PubMed ID: 10063562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Ontario familial breast cancer registry to facilitate genetic and epidemiologic studies.
    Andrulis IL; Boyd NF; Sutherland H
    Can Fam Physician; 1997 May; 43():949-50. PubMed ID: 9154367
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hereditary risks of breast cancer. Interaction of genetic factors and hormonal factors].
    Plu-Bureau G; Thalabard JC
    Ann Endocrinol (Paris); 1998; 59(6):465-9. PubMed ID: 10189989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The involvement of genetic factors in susceptibility to breast cancer.
    Bishop DT
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():125-30. PubMed ID: 8298442
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular epidemiology of lung and breast cancer.
    Ambrosone CB; Kato S; Bowman ED; Harrington AM; Blomeke B; Freudenheim JL; Graham S; Marshall JR; Vena JE; Brasure JR; Shields PG
    Eur J Cancer Prev; 1996 Oct; 5(5):391-2. PubMed ID: 8972270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.